Results 31 to 40 of about 38,562 (258)

Cardiac Dysfunction, Congestion and Loop Diuretics: their Relationship to Prognosis in Heart Failure [PDF]

, 2016
Background: Diuretics are the mainstay of treatment for congestion but concerns exist that they adversely affect prognosis. We explored whether the relationship between loop diuretic use and outcome is explained by the underlying severity of ...
A Shoaib, Alessia Urbinati, Andrew L Clark, Anna Kallvikbacka-Bennett, DJ Kraaij van, GS Francis, GW Neuberg, J Bayliss, JG Cleland, JG Cleland, JG Cleland, JG Cleland, JG Lainchbury, JJ McMurray, JM Ter Maaten, John G. F. Cleland, JS Hanberg, Jufen Zhang, K Damman, K Dickstein, LW Stevenson, M Domanski, M Pfisterer, P Jourdain, P Pellicori, P Pellicori, P Pellicori, P Pellicori, P Pellicori, Parin Shah, PB Adamson, Pierpaolo Pellicori, RM Lang, RW Troughton, S Eshaghian, S Gupta, Syed Kazmi, T Damy, WT Abraham   +38 more
core   +2 more sources

Outcomes Associated With a Strategy of Adjuvant Metolazone or High‐Dose Loop Diuretics in Acute Decompensated Heart Failure: A Propensity Analysis

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2018
Background In acute decompensated heart failure, guidelines recommend increasing loop diuretic dose or adding a thiazide diuretic when diuresis is inadequate.
Meredith A. Brisco‐Bacik, Jozine M. ter Maaten, Steven R. Houser, Natasha A. Vedage, Veena Rao, Tariq Ahmad, F. Perry Wilson, Jeffrey M. Testani   +7 more
doaj   +1 more source

Loop Diuretic Absorption [PDF]

Congestive Heart Failure, 2000
Objectives. The present study was undertaken to determine if direct blockade of angiotensin II receptors by losartan potassium as compared to ACE inhibition might result in greater tolerability in patients with congestive heart failure in whom ACE inhibition resulted in hyperkalemia and azotemia.Background.
James Blake, Richard B. Devereux
openaire   +1 more source

Patterns of antihypertensive prescribing, discontinuation and switching among a Hong Kong Chinese population from over one million prescriptions [PDF]

, 2008
Hypertension is an alarming public health problem among Chinese. The present study evaluated the prescribing patterns, discontinuation and switching profiles of antihypertensive agents and their associated factors in one Hong Kong Chinese population ...
A Fretheim, A T Lam, BM Cheung, G Onder, H Fung, H Mori, J Ma, J Y Jiang, M C S Wong, MCS Wong, S Griffiths, S W Mercer, T Walley, YH Yuen, Z Kabir   +14 more
core   +1 more source

The EuroHeart Failure Survey programme—a survey on the quality of care among patients with heart failure in Europe Part 2: treatment [PDF]

, 2003
National surveys suggest that treatment of heart failure in daily practice differs from guidelines and is characterized by underuse of recommended medications.
Aguilar, JC, Cleland, J, Cohen-Solal, A, Dietz, R, Eastaugh, J, Follath, F, Freemantle, N, Gavazzi, A, Hobbs, R, Komajda, M, Korewicki, J, Madeira, HC, Mason, J, Moiseyev, VS, Preda, I, Swedberg, K, Van Gilst, WH, Widimsky, J   +17 more
core   +12 more sources

Heart Failure Drug Class Effects on 30-Day Readmission Rates in Patients with Heart Failure with Preserved Ejection Fraction: A Retrospective Single Center Study

Medicines, 2020
Background: The pharmacologic management of heart failure with preserved ejection fraction (HFpEF) involves far fewer options with demonstrated additional benefit.
Priyanka Parajuli, Odalys Estefania Lara-Garcia, Manjari Rani Regmi, Warren Skoza, Mukul Bhattarai, Abhishek Kulkarni, Robert Leonard Robinson   +6 more
doaj   +1 more source

Loop Diuretics

, 2012
James W. Davis, Dana Forman, La Scienya M. Jackson, James W. Davis, Javier Garau, David N. O’Dwyer, Elisa Vedes, Gihan Abuella, Maurizio Cecconi, Howard A. Greller, Michelle K. McNutt, Rosemary A. Kozar, Jorge Cerdá, Andrew Davenport, Abhay Dhand, Gary P. Wormser   +15 more
europepmc   +2 more sources

B-type natriuretic peptide-guided treatment for heart failure [PDF]

, 2016
Background Heart failure is a condition in which the heart does not pump enough blood to meet all the needs of the body. Symptoms of heart failure include breathlessness, fatigue and fluid retention.
Bankhead, Clare, Clements, Alison M, Glasziou, Paul P, Heneghan, Carl J., Kearley, Karen E, McLellan, Julie, Perera, Rafael, Pidduck, Nicola, Roberts, Nia W, Tyndel, Sally, Wright, F Lucy   +10 more
core   +1 more source

Why do SGLT2 inhibitors reduce heart failure hospitalization? A differential volume regulation hypothesis [PDF]

, 2017
The effect of a sodium glucose cotransporter 2 inhibitor (SGLT2i) in reducing heart failure hospitalization in the EMPA-REG OUTCOMES trial has raised the possibility of using these agents to treat established heart failure.
De Vecchis, Ferrannini, Fitchett, Francis, Greenberg, Hammon, Heise, Heise, Hirose, Lindner, Neal, Peacock, Rabe, Schmieder, Schneider, Schrier, Schrier, Shimizu, Titze, Titze, Titze, Weinfeld, Zinman   +22 more
core   +1 more source

Use of Loop Diuretics is Associated with Increased Mortality in Patients with Suspected Coronary Artery Disease, but without Systolic Heart Failure or Renal Impairment: An Observational Study Using Propensity Score Matching.

PLoS ONE, 2015
BACKGROUND:Loop diuretics are widely used in patients with heart and renal failure, as well as to treat hypertension and peripheral edema. However, there are no randomized, controlled trials (RCT) evaluating their long term safety, and several ...
Hall Schartum-Hansen, Kjetil H Løland, Gard F T Svingen, Reinhard Seifert, Eva R Pedersen, Jan E Nordrehaug, Øyvind Bleie, Marta Ebbing, Christ Berge, Dennis W T Nilsen, Ottar Nygård   +10 more
doaj   +1 more source